Clinical trial tests AI-assisted medication device for older adults with memory loss
Marianne Blake has lived in the same home for nearly half a century. She plays bridge regularly, drives to her hair appointments and, at 88 years old, enjoys her independence.
A clinical trial is underway at UC Davis Health to evaluate the effectiveness of an AI-assisted, home-based medication device for older adults with memory loss. The study, funded by a $2.48 million grant from the National Institute on Aging, aims to determine if the device can help individuals with mild cognitive impairment or dementia take their prescribed medication while providing peace of mind to caregivers.
The device, created by HiDO Health, is designed to dispense the correct medication at the appropriate time, confirm the identity of the person taking it, and record that the medication was taken. Unlike simpler medication tools that only alert caregivers when a pill has been removed, the HiDO device provides confirmation that the medication has been ingested.
The trial will enroll 50 participants with a range of cognitive impairments, and researchers will assess medication adherence, cognitive function, and daily functioning over a period of one year. The device's ability to provide real-time information to caregivers may reduce uncertainty and the need for frequent reminders, ultimately helping older adults maintain their independence.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
